A spokesperson for the DEA affirmed that the change is only specific to Epidiolex, and does not amend the schedule I status of either whole-plant cannabis or CBD — stating: “As of right now, any other CBD product other than Epidiolex remains a Schedule I Controlled Substance, so it’s still illegal under federal law.”